Building Oncofertility Core Competency in Developing Countries: Experience From Egypt, Tunisia, Brazil, Peru, and Panama.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
2020
2020
Historique:
accepted:
17
10
2017
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
29
7
2021
Statut:
epublish
Résumé
Little is known about oncofertility practice in developing countries that usually suffer from a shortage of health services, especially those related to cancer care. To learn more about oncofertility practice in developing countries, we generated a survey to explore the barriers and opportunities associated with oncofertility practice in five developing countries from Africa and Latin America within our Oncofertility Consortium Global Partners Network. Responses from Egypt, Tunisia, Brazil, Peru, and Panama were collected, reviewed, and discussed. Common barriers were identified by each country, including financial barriers (lack of insurance coverage and high out-of-pocket costs for patients), lack of awareness among providers and patients, cultural and religious constraints, and lack of funding to help to support oncofertility programs. Despite barriers to care, many opportunities exist to grow the field of oncofertility in these five developing countries. It is important to continue to engage stakeholders in developing countries and use powerful networks in the United States and other developed countries to aid in the acceptance of oncofertility on a global level.
Identifiants
pubmed: 32259156
doi: 10.1200/JGO.17.00121
pii: 1700121
pmc: PMC7853873
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NICHD NIH HHS
ID : P50 HD076188
Pays : United States
Commentaires et corrections
Type : ErratumIn
Type : RepublishedIn
Informations de copyright
© 2020 by American Society of Clinical Oncology.
Références
J Cancer Epidemiol. 2014;2014:437971
pubmed: 25328522
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259160
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Cancer Treat Res. 2007;138:3-11
pubmed: 18080653
JBRA Assist Reprod. 2016 May 01;20(2):49-58
pubmed: 27244761
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Hum Reprod. 2016 Jul;31(7):1588-609
pubmed: 27207175
JBRA Assist Reprod. 2014 Mar 27;18(1):16-23
pubmed: 35761719
Int J Gynaecol Obstet. 2013 Jan;120(1):23-6
pubmed: 23099050
J Clin Oncol. 2013 Jul 1;31(19):2500-10
pubmed: 23715580
Lancet. 2014 Oct 4;384(9950):1302-10
pubmed: 25283571
Fertil Steril. 2013 Nov;100(5):1214-23
pubmed: 24011612
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103
pubmed: 24488779
Fertil Steril. 2015 Feb;103(2):402-13.e11
pubmed: 25516078
Reproduction. 2015 Sep;150(3):S1-10
pubmed: 26130814
J Glob Oncol. 2016 Apr;2(2):83-96
pubmed: 27284576
N Engl J Med. 2009 Feb 26;360(9):902-11
pubmed: 19246362
Soc Sci Med. 2003 May;56(9):1837-51
pubmed: 12650724
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Rev Peru Med Exp Salud Publica. 2013 Mar;30(1):105-12
pubmed: 23612822
JCO Glob Oncol. 2020 Mar 2;6:
pubmed: 32259159
Gynecol Endocrinol. 2013 Nov;29(11):949-52
pubmed: 24004295
J Clin Oncol. 2006 Jun 20;24(18):2917-31
pubmed: 16651642